---
title: "Autobio and its wholly-owned subsidiary obtained medical device registration certificates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/259296447.md"
description: "Autobio and its wholly-owned subsidiary, Antu Instruments, recently obtained medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration. The acquisition of this registration certificate enriches the company's product line, meets market demand, and effectively supplements existing testing products, enhancing overall competitiveness, but has a relatively small impact on operating performance in the short term"
datetime: "2025-09-29T09:28:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/259296447.md)
  - [en](https://longbridge.com/en/news/259296447.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/259296447.md)
---

# Autobio and its wholly-owned subsidiary obtained medical device registration certificates

According to the Zhitong Finance APP, Autobio (603658.SH) announced that the company and its wholly-owned subsidiary Autobio Instrument (Zhengzhou) Co., Ltd. (referred to as "Autobio Instrument") recently received medical device registration certificates issued by the National Medical Products Administration and the Henan Provincial Medical Products Administration.

The acquisition of the above medical device registration certificates further enriches the company's product menu, continuously meets market demand, serves as an effective supplement to the company's existing testing products, and can gradually enhance the overall competitiveness of the company's products, with a relatively small impact on the company's operating performance in the short term

### Related Stocks

- [603658.CN](https://longbridge.com/en/quote/603658.CN.md)

## Related News & Research

- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [10:45 ETInventHelp Inventor Develops New Illuminated Display (SGM-649)](https://longbridge.com/en/news/286933598.md)
- [AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain](https://longbridge.com/en/news/286879044.md)
- [BCAL Diagnostics Expands National Access to Early Cancer Detection Blood Tests](https://longbridge.com/en/news/286850851.md)
- [Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities | DTCFF Stock News](https://longbridge.com/en/news/286870222.md)